![Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial]()
Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trialRamanakumar, Agnihotram V; Naud, Paulo; Roteli-Martins, Cecilia M; de Carvalho, Newton S; de Borba, Paola C; Teixeira, Julio C; Blatter, Mark; Moscicki, Anna-Barbara; Harper, Diane M; Romanowski, Barbara; Tyring, Stephen K; Ramjattan, Brian; Schuind, Anne; Dubin, Gary; Franco, Eduardo L · BMJ Open · 2016